Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of 3α-diol G are linked to more severe female pattern hair loss.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Higher levels of a specific hormone are linked to more chest hair and acne in men.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Caucasian men have more chest hair and higher levels of certain androgen products than Chinese men.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Sebocytes play a key role in controlling androgen levels in human skin.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Testosterone increases seizure risk through its conversion to specific neurosteroids.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Finasteride safely lowers DHT levels without affecting testosterone.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.